Robert J. Dalton

3.3k total citations
34 papers, 1.0k citations indexed

About

Robert J. Dalton is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert J. Dalton has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert J. Dalton's work include Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers) and Cutaneous Melanoma Detection and Management (3 papers). Robert J. Dalton is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers) and Cutaneous Melanoma Detection and Management (3 papers). Robert J. Dalton collaborates with scholars based in United States, Canada and Australia. Robert J. Dalton's co-authors include Edward T. Creagan, Roscoe F. Morton, James E. Krook, Sung‐Hoon Jung, James A. Mailliard, J. W. Kugler, David L. Ahmann, Robert M. Langdon, Charles L. Loprinzi and Michael H. Veeder and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Robert J. Dalton

33 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J. Dalton United States	16	561	380	356	156	134	34	1.0k
Toshiyuki Ishibashi Japan	13	334 0.6×	437 1.1×	612 1.7×	314 2.0×	203 1.5×	38	1.5k
Karl-Heinz Pflüger Germany	11	216 0.4×	291 0.8×	400 1.1×	69 0.4×	132 1.0×	42	778
Eija Mahlamäki Finland	19	641 1.1×	781 2.1×	383 1.1×	85 0.5×	103 0.8×	35	1.7k
Sakae Tanosaki Japan	13	293 0.5×	363 1.0×	319 0.9×	196 1.3×	131 1.0×	33	905
Shripad Sinari United States	13	216 0.4×	407 1.1×	241 0.7×	131 0.8×	70 0.5×	22	891
Kenneth B. DeSantes United States	16	354 0.6×	275 0.7×	322 0.9×	354 2.3×	108 0.8×	32	1.1k
Jean-Michel Lutz Switzerland	7	299 0.5×	162 0.4×	260 0.7×	71 0.5×	247 1.8×	9	856
Stephen Krauss United States	16	240 0.4×	146 0.4×	206 0.6×	143 0.9×	161 1.2×	33	891
S. Rubin Canada	10	562 1.0×	269 0.7×	226 0.6×	46 0.3×	52 0.4×	20	960
Salah Aref Egypt	16	180 0.3×	304 0.8×	341 1.0×	198 1.3×	124 0.9×	90	831

Countries citing papers authored by Robert J. Dalton

Since Specialization

Citations

This map shows the geographic impact of Robert J. Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Dalton more than expected).

Fields of papers citing papers by Robert J. Dalton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Dalton. The network helps show where Robert J. Dalton may publish in the future.

Co-authorship network of co-authors of Robert J. Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Dalton. A scholar is included among the top collaborators of Robert J. Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Dalton. Robert J. Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hines, Stephanie L., Jeff A. Sloan, Philip J. Atherton, et al.. (2010). Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy. The Breast. 19(2). 92–96. 24 indexed citations

2.

Tracy, C. Richard, Claire Streten, Robert J. Dalton, et al.. (2009). Microclimate and limits to photosynthesis in a diverse community of hypolithic cyanobacteria in northern Australia. Environmental Microbiology. 12(3). 592–607. 53 indexed citations

3.

Witzig, Thomas E., Susan M. Geyer, Paul J. Kurtin, et al.. (2008). Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group. Leukemia & lymphoma. 49(6). 1074–1080. 38 indexed citations

4.

Dispenzieri, Angela, S. Vincent Rajkumar, Morie A. Gertz, et al.. (2007). Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement. Mayo Clinic Proceedings. 82(3). 323–341. 113 indexed citations

5.

Dispenzieri, Angela, S. Vincent Rajkumar, Morie A. Gertz, et al.. (2007). Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement. Mayo Clinic Proceedings. 82(3). 323–341. 105 indexed citations

6.

Algazi, V. Ralph, et al.. (2005). Motion-Tracked Binaural Sound for Personal Music Players. Journal of the Audio Engineering Society. 2 indexed citations

7.

Markovic, Svetomir N., Vera J. Suman, Robert J. Dalton, et al.. (2002). Randomized, Placebo-Controlled, Phase III Surgical Adjuvant Clinical Trial of Megestrol Acetate (Megace) in Selected Patients With Malignant Melanoma. American Journal of Clinical Oncology. 25(6). 552–556. 9 indexed citations

8.

Edmonson, John H., Vera J. Suman, Robert J. Dalton, et al.. (2001). Comparison of Conventional Dose and Double Dose Carboplatin in Patients Receiving Cyclophosphamide Plus Carboplatin for Advanced Ovarian Carcinoma: A North Central Cancer Treatment Group Study. Cancer Investigation. 19(6). 597–602. 7 indexed citations

9.

Burch, Patrick A., Georgene Schroeder, Joseph Rubin, et al.. (1999). North Central Cancer Treatment Group Phase II Study of 5-Fluorouracil and High-Dose Levamisole for Gastric and Gastroesophageal Cancer Using Survival as the Primary Endpoint of Efficacy. American Journal of Clinical Oncology. 22(5). 505–505. 3 indexed citations

10.

Ingle, James N., Vera J. Suman, Carl G. Kardinal, et al.. (1999). A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer. 85(6). 1284–1292. 53 indexed citations

11.

Akhtar, Salman, K. B. Johnson, Robert J. Dalton, et al.. (1999). Balloon rupture during stent implantation: A novel technique of salvage with a new manual power injector. Catheterization and Cardiovascular Interventions. 48(1). 74–77. 1 indexed citations

12.

Creagan, Edward T., Michael H. Veeder, Vera J. Suman, et al.. (1998). A Phase II Study of High-Dose Cimetidine and the Combination 5-Fluorouracil, Interferon Alpha-2A, and Leucovorin in Advanced Renal Cell Adenocarcinoma. American Journal of Clinical Oncology. 21(5). 475–478. 3 indexed citations

13.

Tefferi, Ayalew, Curtis A. Hanson, Paul J. Kurtin, et al.. (1997). Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells. British Journal of Haematology. 96(4). 850–853. 39 indexed citations

14.

Rubin, Joseph, James Gallagher, Georgene Schroeder, et al.. (1996). Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma. Cancer. 78(9). 1888–1891. 42 indexed citations

15.

Creagan, Edward T., Robert J. Dalton, David L. Ahmann, et al.. (1995). Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.. Journal of Clinical Oncology. 13(11). 2776–2783. 170 indexed citations

16.

Moertel, Charles G., H. Samuel Wieand, James E. Krook, et al.. (1995). A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. Cancer. 76(6). 961–966. 32 indexed citations

17.

Veeder, Michael H., James R. Jett, John Q. Su, et al.. (1992). A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma. Cancer. 70(9). 2281–2287. 26 indexed citations

18.

Ingle, James N., Harry J. Long, Charles L. Loprinzi, et al.. (1991). A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the north central cancer treatment group and mayo clinic. Cancer. 68(1). 34–39. 30 indexed citations

19.

Jett, James R., Lloyd K. Everson, Terry M. Therneau, et al.. (1990). Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group.. Journal of Clinical Oncology. 8(1). 33–38. 47 indexed citations

20.

Everson, Lloyd K., James R. Jett, Judith R. OʼFallon, et al.. (1989). Alternating Chemotherapy With or Without VP-16 in Extensive-Stage Small-Cell Lung Cancer. American Journal of Clinical Oncology. 12(4). 339–344. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact